Pfizer’s mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3
By Darren Incorvaia Nov 20, 2025 11:25 am Pfizer influenza vaccine mRNA flu vaccine Both vaccines caused similar side effects, but the mRNA shot had a higher rate of adverse reactions. (Getty Images) Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared […]
Pfizer’s mRNA flu vaccine shows 34.5% greater efficacy than standard shot in phase 3 Read More »
